MARKET INTRODUCTION
Human rabies immune globulin (HRIG) is administered only once, at the beginning of anti-rabies prophylaxis, to previously unvaccinated persons. This will provide immediate antibodies until the body can respond to the vaccine by actively producing antibodies of its own.
MARKET DYNAMICS
The rising incidence of Rabies, which is causing an estimated 59,000 human deaths annually WHO, 2020. Moreover, various strategies adopted by the government will further spur the market growth. For instance, World Health Organization (WHO), the World Organization for Animal Health (OIE), the Food and Agriculture Organization of the United Nations (FAO) and the Global Alliance for Rabies Control (GARC) have developed a country-centric strategic plan to achieve the global goal of zero human dog-mediated rabies deaths by 2030.
MARKET SCOPE
The "Global Human Rabies Immunoglobulin Market analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Human Rabies Immunoglobulin Market with detailed market segmentation by, application, end-users and geography. The Global Human Rabies Immunoglobulin Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Human Rabies Immunoglobulin Market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION

The Global Human Rabies Immunoglobulin Market is segmented on the basis of application and end-users. Based on application the market is segmented into category iii exposures, category ii exposures. By end-user, the market has been divided into hospitals, specialty clinics, and others.
?
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Human Rabies Immunoglobulin Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Human Rabies Immunoglobulin Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Human Rabies Immunoglobulin Market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Human Rabies Immunoglobulin Market in these regions.
MARKET PLAYERS
The report covers key developments in the Human Rabies Immunoglobulin Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Human Rabies Immunoglobulin Market are anticipated to lucrative growth opportunities in the future with the rising demand for Human Rabies Immunoglobulin Market in the global market. Below mentioned is the list of few companies engaged in the Human Rabies Immunoglobulin Market.
The report also includes the profiles of key Human Rabies Immunoglobulin Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Grifols USA, LLC
- Sanofi
- Sichuan Yuanda Shuyang
- CSL Behring
- KEDRAB
- Shanghai RAAS
- Bharat Serum
- Vins Bioproducts Limited.
- Bio Products Laboratory Limited
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization `options in the existing study.